KR20080012546A - Dodok (codonopsis lanceolata) extracts, funtional beverage comprising dodok (codonopsis lanceolata) extracts as main components and method of preparing the same - Google Patents

Dodok (codonopsis lanceolata) extracts, funtional beverage comprising dodok (codonopsis lanceolata) extracts as main components and method of preparing the same Download PDF

Info

Publication number
KR20080012546A
KR20080012546A KR1020060073497A KR20060073497A KR20080012546A KR 20080012546 A KR20080012546 A KR 20080012546A KR 1020060073497 A KR1020060073497 A KR 1020060073497A KR 20060073497 A KR20060073497 A KR 20060073497A KR 20080012546 A KR20080012546 A KR 20080012546A
Authority
KR
South Korea
Prior art keywords
deodeok
extract
effective
weight
antihypertensive
Prior art date
Application number
KR1020060073497A
Other languages
Korean (ko)
Other versions
KR100814382B1 (en
Inventor
김동수
이명기
조진호
이용환
도정룡
김은미
김병목
Original Assignee
한국식품연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국식품연구원 filed Critical 한국식품연구원
Priority to KR1020060073497A priority Critical patent/KR100814382B1/en
Publication of KR20080012546A publication Critical patent/KR20080012546A/en
Application granted granted Critical
Publication of KR100814382B1 publication Critical patent/KR100814382B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/38Other non-alcoholic beverages
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/02Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
    • A23L2/04Extraction of juices
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/70Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
    • A23L2/72Clarifying or fining of non-alcoholic beverages; Removing unwanted matter by filtration
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06Enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/51Concentration
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/20Natural extracts
    • A23V2250/21Plant extracts
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00Processes
    • A23V2300/14Extraction
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00Processes
    • A23V2300/24Heat, thermal treatment
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00Processes
    • A23V2300/50Concentrating, enriching or enhancing in functional factors

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Pediatric Medicine (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

A method of manufacturing a functional beverage containing Codonopsis root extract as an active ingredient is provided to obtain the beverage effective for treatment and prevention of cancer and hypertension and easy to drink. An anticancer and antihypertensive beverage contains 0.01 to 0.1% by weight of Codonopsis root extract and additives containing 1 to 5% by weight of sugars, 0.1 to 0.5% by weight of citric acid, 0.01 to 0.005% by weight of vitamin C and 0.1 to 0.5% by weight of dextrin. The Codonopsis root extract is obtained by extracting Codonopsis root with water, alcohol or enzyme. The water-extract of Codonopsis root is obtained by the steps of: adding Codonopsis root with 2 to 4 times their weight of water; adding 0.5 to 0.9% by weight of enzyme thereto to adjust the pH; extracting at 36 to 38deg.C for 4 to 6hr in an incubator; and freeze-drying to 70 to 90meshes. The alcohol is 30 to 60% ethanol. The enzyme is cellulase.

Description

더덕 추출물, 이를 유효성분으로 하는 기능성 음료 및 그의 제조방법{Dodok (Codonopsis lanceolata) Extracts, Funtional beverage comprising Dodok (Codonopsis lanceolata) Extracts as main components and Method of preparing the same}Deodek extract, functional beverage using the same as an active ingredient, and a method for producing the same

도 1은 실시예 1 내지 5에 따라 제조된 본 발명의 산더덕 추출물을 1, 3, 5, 7, 9, 12mg/ml의 농도에 따른 암세포 증식 억제효과를 측정하여 나타낸 것이며, Figure 1 shows the measurement of cancer cell proliferation inhibitory effect according to the concentration of 1, 3, 5, 7, 9, 12mg / ml of the extract of the present invention prepared according to Examples 1 to 5,

도 2는 실시예 1 내지 5에 따라 제조된 본 발명의 산더덕 추출물의 항고혈압효과에 대한 결과를 나타낸 것이며, Figure 2 shows the results for the antihypertensive effect of the extract of Sandodeok of the present invention prepared according to Examples 1 to 5,

도 3은 본 발명의 일 실시예에 따른 산더덕 추출액 및 음료의 제조공정이며, 3 is a manufacturing process of the sand extract extract and beverage according to an embodiment of the present invention,

도 4는 본 발명의 일 실시예에 따른 산더덕 음료의 제조공정도이다.Figure 4 is a manufacturing process of the sand duck drink according to an embodiment of the present invention.

본 발명은 항암효과와 항고혈압효과를 나타내는 더덕 추출물, 이를 유효성분으로 하는 음료 및 그의 제조방법에 관한 것이다. The present invention relates to a deodeok extract showing an anticancer effect and an antihypertensive effect, a beverage using the same as an active ingredient, and a method for preparing the same.

더덕은 초롱꽃과(Campahutaceae)에 속하는 다년생 덩쿨성 식물로 재배역사는 오래지 않고 주로 야생에서 자라는 것을 채취하여 잔대대용 한약재와 식용으로 하던 것을 순화재배 하게 되었다. 더덕은 편도선염, 궤양, 폐결핵, 천식, 해독, 거담 및 진해 등에 효과가 있는 것으로 알려져 예로부터 사삼이라 불리며 인삼대용으로 널리 이용되어 왔다. 더덕(Codonopsis lanceolata Benth et Hook)의 종류로는 야생더덕인 산더덕과 인공 재배더덕인 밭더덕이 있는데 산더덕이 맛과 향에 있어서 밭더덕 보다 우수하다고 하나 객관적인 자료는 없는 실정이다.Deodeok is a perennial vine plant belonging to Campahutaceae, and its cultivation history is not long, and it has been harvested mainly in the wild, and has been grown for the sake of herbs and edibles. Deodeok is known to be effective in tonsillitis, ulcers, pulmonary tuberculosis, asthma, detoxification, expectoration and cough, and has been widely used as a ginseng substitute for ginseng. Codonopsis lanceolata Benth et Hook) includes wild ducks and wild cultivators, which are superior to the ones in taste and aroma, but there are no objective data.

산더덕은 한국, 중국 및 일본의 산간 지방에서 야생하는 다년생 초본으로서 예로부터 도라지와 함께 일반적인 식품 및 사삼이라 하여 한방에서는 인삼대용으로 민간요법의 약제로도 널리 사용되어왔다. 산더덕은 독특한 풍미로 인해 구이나 절임 식품을 비롯, 생으로도 많이 이용되고 있으며, 일부 가공식품의 원료로도 사용되고 있다. 그러나, 잠재적 이용가치에 비해 아직은 그 활용이 매우 제한되어 있는 실정이다. 따라서 현재까지 알려진 산더덕의 여러 약효는 물론 새로운 생리적 기능을 과학적으로 구명함으로써 산더덕의 식품학적 우수성을 입증함과 함께 이를 이용한 고부가가치 식품소재 및 가공식품을 개발하는 것은 학문적, 기술적 측면 뿐 아니라 경제적 면에서 그 의의가 매우 클 것이다.Sandodeok is a perennial herb that is wild in the mountainous regions of Korea, China, and Japan. Since ancient times, it has been widely used as a folk medicine for ginseng as a common food and ginseng. Due to its unique flavor, sanda duck is widely used for raw foods such as baked and pickled foods, and is used as a raw material for some processed foods. However, its use is still very limited compared to potential use value. Therefore, it is not only academic, technical, but economical to develop high value-added food ingredients and processed foods by demonstrating the scientific excellence of Sandodeok by scientifically exploring the various medicinal effects as well as the new physiological functions. In that sense, the significance is very large.

특히, 현대 성인병의 대부분을 차지하는 고혈압, 암등의 경우 모든 현대인이 극복해야하는 질병이며, 식습관에서 유래한 질병으로 식습관을 개선하거나 또는 상기 질병에 효과가 있는 기능성 식품을 장기복용하는 것으로 이를 예방 및 치유할 수 있다고 할 것이다. 특히 음용이 쉽고 용이하며, 맛이 탁월하여 음용에 거부감이 없는 음료라면 더욱 바람직할 것이다. 본 발명자들은 이러한 관점에서 착안하여, 항암, 항고혈압 특성이 우수한 기능성식품, 특히 음용이 용이한 기능성 음료를 완성하고자 연구하던 중 본 발명을 완성하게 되었다.In particular, hypertension, cancer, etc., which occupy most of modern adult diseases, are diseases that all modern people have to overcome, and these diseases are derived from eating habits to improve their eating habits or to take long-term use of functional foods that are effective for these diseases. I would say. In particular, the drink is easy and easy, and excellent taste, it would be more desirable if the drink does not have a refusal to drink. The inventors of the present invention have completed the present invention while studying to complete a functional food having excellent anti-cancer and antihypertensive properties, in particular, a functional beverage that is easy to drink.

본 발명은 항암 및 항고혈압 예방 및 치료에 효과적인 더덕 추출물, 이를 유효성분으로 하는 항고혈암 및 항암의 예방 및 치료에 효과적인 기능성 건강 음료 및 그 제조방법을 제공하는 것을 목적으로 한다. An object of the present invention is to provide a deodeok extract effective for the prevention and treatment of anticancer and antihypertension, a functional health drink effective for the prevention and treatment of antihypertension and anticancer using the same, and a method for producing the same.

본 발명의 목적을 달성하기 위하여 본 발명은,In order to achieve the object of the present invention,

더덕을 물, 알코올, 또는 효소로 추출하여 얻은 항암 및 항고혈압의 예방 및 치료에 효과적인 더덕 추출물을 특징으로 한다.Deodeok extract, which is effective for the prevention and treatment of anticancer and antihypertension obtained by extracting Deodeok with water, alcohol, or enzyme.

상기 물로 추출한 더덕 추출물은 더덕을 90~150℃에서 3~6 시간동안 더덕 중량의 2~4 배의 물을 가하여 추출하고 여과하여 얻어진 열수 추출물일 수 있다. The deodeok extract extracted with water may be a hydrothermal extract obtained by extracting and filtering Deodeok by adding water 2 to 4 times the weight of Deodeok for 3-6 hours at 90 ~ 150 ℃.

상기 알코올로 추출한 더덕 추출물은 더덕을 90~150℃에서 3~6 시간동안 더덕 중량의 2~4 배의 알코올을 가하여 추출하고 여과하여 얻어진 알코올 추출물일 수 있다. 여기서 상기 알코올은 본 발명의 일 실시예에서 에탄올이 바람직하게 사용될 수 있다. 상기 알코올은 30~60%의 알코올이 바람직하게 사용될 수 있다.Deodeok extract extracted with the alcohol may be an alcohol extract obtained by extracting and filtering the Deodeok 2 ~ 4 times the weight of the deodeok for 3-6 hours at 90 ~ 150 ℃ and filtered. Herein, the alcohol may be preferably used in one embodiment of the present invention. The alcohol is preferably 30 to 60% alcohol.

상기 효소로 추출한 더덕 추출물은 더덕을 더덕의 중량에 2~4 배의 물을 가한 후 0.5~0.9%의 효소를 첨가하여 pH를 4~6으로 조절한 후 36~38℃의 인큐베이터에서 4~6시간 추출한 후 여과지로 여과하여 얻어진 효소 추출물일 수 있다. 여기서 상기 효소는 셀룰라아제(cellulase)가 사용될 수 있다.Deodeok extract extracted with the enzyme was added to 2 ~ 4 times the weight of the deodeok to the weight of the deodeok 0.5 ~ 0.9% of the enzyme is added to adjust the pH to 4 ~ 6 and then 4 ~ 6 in an incubator at 36 ~ 38 ℃ After extracting for time may be an enzyme extract obtained by filtration with filter paper. Herein, the enzyme may be a cellulase.

상기 더덕은 더덕 추출액의 추출수율을 향상시키기 위해 분쇄기를 이용하여 분쇄한 후 추출하는 것이 바람직하다.The deodeok is preferably extracted after grinding using a grinder to improve the extraction yield of the deodeok extract.

상기 더덕 추출물들은 동결하여 동결 건조기로 분말화 한 후 70~90메쉬(mesh)로 여과하여 사용될 수 있다.     The deodeok extracts may be frozen and powdered with a freeze dryer, and then filtered by 70 to 90 mesh.

상기 더덕은 산더덕 또는 밭더덕일 수 있다. The deodeok may be a sand dude or a field deodeok.

본 발명의 또 다른 목적을 위하여, 본 발명은 For another object of the present invention, the present invention

상기 더덕 추출물을 유효성분으로 하여 전체 중량당 0.01~0.1 중량%을 함유하는 항암 및 항고혈압에 효과적인 더덕 기능성 건강음료를 제공한다. 더덕음료 총 중량을 기준으로 더덕추출액이 0.01 중량% 미만이면 더덕의 향과 맛을 전혀 느낄 수 없고, 더덕추출액이 0.1중량% 이상이면 더덕의 향과 쓴맛이 너무 강하여 이들을 음료의 기호도가 감소하는 문제가 있다. 약효적 효과면에서는 고농도일수록 효과적이므로 음용에 이상이 없다면 그 이상 첨가도 가능하며, 또한 저농도일지라도 지속적인 음용으로 인해 그 유용성분이 체내에 축적됨으로써 그 기능을 발휘할 수 있으므로, 더덕의 맛과 풍미를 느끼기 위해서는 상기 유효범위가 바람직하나, 약효적인 면에서는 상기 범위를 벗어나서도 사용될 수 있다.     It provides a deodeok functional health drink effective in anti-cancer and antihypertensive containing 0.01 ~ 0.1% by weight of the deodeok extract as an active ingredient. If the deodeok extract is less than 0.01% by weight based on the total weight of the Deodeok beverage, you can not feel the aroma and taste of the deodeok at all, and if the deodeok extract is more than 0.1% by weight, the aroma and bitter taste of the deodeok is too strong to reduce the preference There is. In terms of pharmacological effects, the higher the concentration, the more effective it is possible to add more if there is no problem in drinking, and even at low concentrations, since the useful ingredients can accumulate in the body due to continuous drinking, the function can be exerted. Although the above-mentioned effective range is preferable, it may be used outside the range in view of efficacy.

상기 더덕 추출물은 열수 추출물이 바람직하다.The deodeok extract is preferably a hot water extract.

상기 더덕 추출액은 저장성을 높이기 위해 추출액을 최대 60 브릭스(Brix)까지 농축하여 더덕 음료의 주성분으로 사용할 수 있다. The deodeok extract can be used as a main ingredient of the deodeok beverage by concentrating the extract to up to 60 Brix (Brix) to increase the shelf life.

상기 더덕 기능성 건강음료는 기타 첨가제로서, 당류 1~5중량%, 구연산 0.1~0.5중량%, 비타민 C 0.01~0.005중량%, 덱스트린 0.1~0.5중량%를 더 포함할 수 있다. The deodeok functional health drink may further include 1 to 5% by weight of sugar, 0.1 to 0.5% by weight of citric acid, 0.01 to 0.005% by weight of vitamin C, 0.1 to 0.5% by weight of dextrin.

본 발명의 또 다른 목적을 위하여 본 발명은For another object of the present invention

더덕을 분쇄기로 분쇄하는 단계,Grinding the deodeok with a grinder,

상기 분쇄된 더덕을 물, 알코올 또는 효소로 추출하는 단계,Extracting the pulverized deodeok with water, alcohol or enzyme,

상기 더덕 추출물을 유효성분으로 하여 총 음료 중량에 대하여 0.01~0.1중량%로 포함되도록 정제수를 혼합하는 단계를 포함하는 항암 및 항고혈압에 효과적인 더덕 기능성 건강 음료의 제조방법을 제공한다.Provides a method for producing a deodeok functional health drink effective in anti-cancer and antihypertensive comprising the step of mixing purified water so as to include 0.01 ~ 0.1% by weight relative to the total beverage weight by using the deodeok extract as an active ingredient.

상기 더덕 기능성 건강 음료의 제조방법은 상기 추출물을 여과하는 단계를 더 포함할 수 있다. The manufacturing method of the deodeok functional health drink may further comprise the step of filtering the extract.

상기 물로 추출한 더덕 추출물은 더덕을 90~150℃에서 3~6 시간동안 더덕 중량의 2~4 배의 물을 가하여 추출하고 여과하여 얻어진 열수 추출물일 수 있다. The deodeok extract extracted with water may be a hydrothermal extract obtained by extracting and filtering Deodeok by adding water 2 to 4 times the weight of Deodeok for 3-6 hours at 90 ~ 150 ℃.

상기 알코올로 추출한 더덕 추출물은 더덕을 90~150℃에서 3~6 시간동안 더덕 중량의 2~4 배의 알코올을 가하여 추출하고 여과하여 얻어진 알코올 추출물일 수 있다. 여기서 상기 알코올은 본 발명의 일 실시예에서 에탄올이 바람직하게 사용될 수 있다. 상기 알코올은 30~60%의 알코올이 바람직하게 사용될 수 있다. Deodeok extract extracted with the alcohol may be an alcohol extract obtained by extracting and filtering the Deodeok 2 ~ 4 times the weight of the deodeok for 3-6 hours at 90 ~ 150 ℃ and filtered. Herein, the alcohol may be preferably used in one embodiment of the present invention. The alcohol is preferably 30 to 60% alcohol.

상기 효소로 추출한 더덕 추출물은 더덕을 더덕의 중량에 2~4 배의 물을 가한 후 0.5~0.9%의 효소를 첨가하여 pH를 4~6으로 조절한 후 36~38℃의 인큐베이터에서 4~6시간 추출한 후 여과지로 여과하여 얻어진 효소 추출물일 수 있다. 여기서 상기 효소는 셀룰라아제(cellulase)가 사용될 수 있다.Deodeok extract extracted with the enzyme was added to 2 ~ 4 times the weight of the deodeok to the weight of the deodeok 0.5 ~ 0.9% of the enzyme is added to adjust the pH to 4 ~ 6 and then 4 ~ 6 in an incubator at 36 ~ 38 ℃ After extracting for time may be an enzyme extract obtained by filtration with filter paper. Herein, the enzyme may be a cellulase.

또한 더덕액과 정제수를 혼합하는 단계에서 더덕 음료의 기호성과 기능성을 향상시키기 위해 공지의 식품첨가물을 부재료로 첨가할 수 있다. In addition, in order to improve the palatability and functionality of the deodeok beverage in the step of mixing the deodeok solution and purified water, a known food additive may be added as a subsidiary material.

상기 더덕 기능성 건강음료의 제조방법은 기타 식품첨가제로서, 당류 1~5중량%, 구연산 0.1~0.5중량%, 비타민 C 0.01~0.005중량%, 덱스트린 0.1~0.5중량%를 더 첨가하는 단계를 포함할 수 있다. The manufacturing method of the deodeok functional health drink, as other food additives, may include adding 1 to 5% by weight of sugar, 0.1 to 0.5% by weight citric acid, 0.01 to 0.005% by weight of vitamin C, 0.1 to 0.5% by weight of dextrin Can be.

한편, 상기의 첨가제는 음료분야에 사용되는 식품첨가물의 일종으로서 당해 기술분야에서 통상의 지식을 가진 자라면 이러한 첨가제는 적절하게 선택하여 사용할 수 있으므로 본 발명의 더덕 음료 제조에 있어서 식품 첨가제는 상기의 식품첨가물에만 한정되는 것이 아니라 소비자의 기호에 맞추어 다양한 식품첨가제를 사용할 수 있다. On the other hand, the additive is a kind of food additives used in the beverage field, if one of ordinary skill in the art such additives can be selected and used appropriately, so the food additive in the deodeok beverage of the present invention is Not only the food additives but various food additives can be used according to the consumer's preference.

본 발명의 일 실시예에 따른 산 더덕 음료는 도 4에 도시된 바와 같이 원재료 배합단계; 이물질 제거 단계; 예열 단계; 탈기 단계; 살균 단계; 충진 단계; 밀봉 단계; 캡 살균단계; 냉각 단계 및 포장 단계로 이루어질 수 있다.      Acid deodeok beverages according to an embodiment of the present invention is a raw material blending step as shown in Figure 4; Foreign material removal step; Preheating step; Degassing step; Sterilization step; Filling step; Sealing step; Cap sterilization step; It may consist of a cooling step and a packing step.

이하 본 발명을 실시예를 통해 더욱 상세히 설명한다. 그러나 하기 실시예들은 예시의 방법으로 기재된 것으로 본 발명의 범위를 한정하는 것으로 해석되어서는 안된다. Hereinafter, the present invention will be described in more detail with reference to Examples. However, the following examples are described by way of example and should not be construed as limiting the scope of the invention.

실시예Example 1:  One: 산더덕Sanderuck 열수Hydrothermal 추출물의 제조 Preparation of Extract

산더덕 1Kg을 잘 수세하여 이물질을 제거한 후 분쇄기를 이용하여 분쇄하고, 100℃에서 4시간동안 더덕 중량의 3배의 물을 가하여 추출하고 Toyo No 5C 여과지로 여과하여 산더덕 열수 추출물 3700mL을 얻었다. 이렇게 얻어진 추출물을 -40℃에서 동결하여 동결 건조기로 분말화 한 후 80mesh로 여과하여 산더덕 열수 추출 분말 50g을 얻었다. 1Kg of sandalwood was washed well to remove foreign substances, and then pulverized using a pulverizer, and extracted by adding three times the weight of sandalwood at 100 ° C for 4 hours, and filtered through a Toyo No 5C filter paper to obtain 3700mL of sandalwood hot water extract. The extract thus obtained was frozen at −40 ° C., powdered with a freeze dryer, filtered through 80mesh to obtain 50 g of hot water extract powder.

실시예Example 2~4:  2-4: 산더덕Sanderuck 에탄올 추출물의 제조 Preparation of Ethanol Extract

산더덕 1Kg을 잘 수세하여 이물질을 제거한 후 분쇄기를 이용하여 분쇄하고, 100℃에서 4시간동안 더덕 중량의 3배의 50%, 70%, 100%의 에탄올을 각각 가하여 추출하고 Toyo No 5C 여과지로 여과한 후 용매를 모두 제거하도록 농축하여 산더덕 에탄올 추출물 3700mL을 얻었다. 또한, 추출한 추출물을 -40℃로 동결하여 동결건조기로 분말화 한 후 80mesh로 여과하여 산더덕 에탄올 추출 분말 40g을 얻었다. 1Kg of sandalwood was washed well to remove foreign substances, and then pulverized by using a grinder. Extracted by adding 50%, 70%, and 100% ethanol, three times the weight of deodeok, was extracted for 4 hours at 100 ° C. with Toyo No 5C filter paper. After filtration, the solvent was concentrated to remove all solvents, thereby obtaining 3700 mL of extract ethanol. In addition, the extracted extract was frozen at −40 ° C., powdered with a freeze dryer, and filtered through 80 mesh to obtain 40 g of ethanol extract powder.

실시예Example 5:  5: 산더덕Sanderuck 효소 추출물의 제조 Preparation of Enzyme Extracts

산더덕 1Kg을 잘 수세하여 이물질을 제거한 후 분쇄기를 이용하여 분쇄하고, 더덕 중량의 3배의 물을 가한 후 0.75%의 효소를 첨가하고 pH를 5.0으로 조절한 후 37℃ Incubator에서 4시간동안 추출하고 Toyo No 5C 여과지로 여과한 후 산더덕 효소 추출물 3700mL을 얻었다. 상기 추출물을 -40℃에서 동결하여 동결건조기로 분말화 한 후 80mesh로 여과하여 산더덕 효소 추출 분말 50g을 얻었다.1Kg of sandalwood was washed well to remove foreign substances, and then pulverized by using a pulverizer. After adding water three times the weight of deodeok, 0.75% of enzyme was added and the pH was adjusted to 5.0. After filtering with Toyo No 5C filter paper, 3700 mL of the extract of Sandus enzyme was obtained. The extract was frozen at −40 ° C., powdered with a lyophilizer, and filtered through 80mesh to obtain 50 g of the enzyme extract powder.

실험예Experimental Example 1:  One: 산더덕Sanderuck 추출물의 암세포 증식 억제 실험 ( Inhibition of Cancer Cell Proliferation by Extracts CytotoxityCytotoxity ))

MTT assay 에 의한 세포 독성 (cytotoxity) 측정은 SNU-1(human gastric adenocarcinoma:위암세포)을 96 well plate에 1×104 cells/well 이 되게 130 μL씩 주입한 다음, 시료를 14.5 μL/well씩 첨가하였고, 37℃, 5% CO2 Incubator에서 72hr 동안 배양하였다. 암세포 성장 억제 작용에 샘플이 함유한 염농도는 암 세포 성장에 큰 영향을 끼치므로 각 샘플의 염농도에 맞는 용액을 제조하여 각각의 대조구로 사용하였다. 72hr 배양 후 인산생리식염수에 5 mg/mL 농도로 제조한 MTT(microtetrazoline; 시그마사) 용액을 한 well당 14.5 μL씩 넣은 후 각 well당 디메틸술폭시드(DMSO) 108.5 μL를 가하여 ELISA(Enzyme-Linked Immunosorbent Assay) reader 로 550nm에서 흡광도를 측정하여 하기 수학식 1으로 Cytotoxity (%)를 구하여 세포 독성 활성의 지표로 하였다.Cytotoxity measurement by MTT assay was performed by injecting 130 mL of SNU-1 (human gastric adenocarcinoma (gastric cancer cell) into 96 well plates at 1 × 10 4 cells / well and then 14.5 μL / well It was added and incubated for 72hr in 37 ° C., 5% CO 2 Incubator. Since the salt concentration contained in the sample has a great effect on the growth of cancer cells, the solution suitable for the salt concentration of each sample was prepared and used as each control. After 72hr incubation, 14.5 μL of MTT (microtetrazoline (Sigma)) solution prepared at 5 mg / mL in phosphate saline solution was added to each well, and 108.5 μL of dimethyl sulfoxide (DMSO) was added to each well, followed by ELISA (Enzyme-Linked). Absorbance was measured at 550 nm with an immunosorbent assay reader to obtain Cytotoxity (%) as the following Equation 1 as an index of cytotoxic activity.

Figure 112006055948393-PAT00001
Figure 112006055948393-PAT00001

실시예 1 내지 5에 따라 제조된 각각의 열수 추출물, 에탄올추출물, 효소가수분해물을 1, 3, 5, 7, 9, 12mg/ml의 농도에 따른 암세포 증식 억제효과를 측정하여 Fig 1에 나타내었다. The hydrothermal extracts, ethanol extracts, and enzyme hydrolysates prepared according to Examples 1 to 5 were shown in Fig. 1 by measuring the effect of inhibiting cancer cell proliferation according to the concentrations of 1, 3, 5, 7, 9, and 12 mg / ml. .

도 1에 표시된 바와 같이, 본 발명에 따른 산더덕 추출물 모두 암세포 증식 억제 효과를 나타내었으며, 그중 열수 추출물의 암세포 증식억제 효과와 전체적인 농도 범위에서 높은 억제 활성을 나타내었고, EtOH추출물은 EtOH 농도가 낮은 추출물이 높은 암세포 증식억제효과를 나타내었다. 본 발명에 따른 효소 추출물은 샘플구 중 가장 낮은 암세포 증식억제 효과를 나타내었지만, 이 역시 암세포 증식 억제 효과를 나타낸 것을 알 수 있다. 열수 추출의 경우 1.0~12.0 mg/mL에서 18.0~70.0%로 추출구 중 가장 높은 암세포 증식억제 효과를 나타내었으며, 다음으로 50% EtOH 추출구에서 16.0~52.0%의 효능을 나타내었으며 EtOH의 농도가 증가된 추출구 일수록 낮은 암세포 증식억제 효과를 나타내었다. 효소 추출구는 추출구 중 가장 낮은 암세포 증식억제효과를 나타내었으며 12.0 mg/mL에서 39%의 증식억제율을 나타내었다.As shown in Fig. 1, all of the extracts of the present invention showed cancer cell proliferation inhibitory effect, among them, the hot water extract showed a cancer cell proliferation inhibitory effect and a high inhibitory activity in the overall concentration range, and the EtOH extract had a low EtOH concentration. The extract showed high cancer cell proliferation inhibitory effect. Enzyme extract according to the present invention showed the lowest cancer cell proliferation inhibitory effect in the sample sphere, it can be seen that also showed the cancer cell proliferation inhibitory effect. In the case of hot water extraction, 18.0 ~ 70.0% at 1.0 ~ 12.0 mg / mL showed the highest cancer cell proliferation inhibitory effect, followed by 16.0 ~ 52.0% at 50% EtOH extract. The increased extractor showed lower cancer cell proliferation inhibitory effect. The enzyme extract showed the lowest cancer cell proliferation inhibitory effect and showed 39% proliferation inhibition rate at 12.0 mg / mL.

실험예Experimental Example 2:  2: 산더덕Sanderuck 추출물의 항고혈압효과 Antihypertensive Effect of Extracts

안지오텐신-I 전환효소(Angiotensin-I Converting Enzyme: ACE)는 토끼의 허파의 (종전 토끼의 허파에서 얻은 물질) 아세톤 분말로 정제한 1 g에 400 mM 소듐 보레이트 완충액(sodium borate buffer, pH 8.3) 10.0 mL를 가한 다음 5℃에서 24hr 교반한 후 원심분리하여 얻은 상등액을 ACE 조효소액으로 사용하였다. 실시예 1 내지 5에 따라 얻은 추출분말 각각의 시료 50 μL에 ACE 조효소액 50 μL 및 0.1 M Sodium borate buffer (pH 8.3) 100 μL를 가한 다음 37℃에서 5분간 배양전시험(Preincubation)을 하였다. 여기에 기질로써 0.5 mM His-His-Leu 50 μL를 첨가하여 37℃에서 30분간 반응시킨 후 1 N HCl 250 μL를 가하여 반응을 정지시켰다. 여기에 에틸아세테이트(Ethyl acetate) 1.5 mL를 가하여 15초간 교반한 후 200×g에서 5분간 원심 분리시켜 상등액을 취하였다. 이 상등액을 완전히 건조시킨 뒤 증류수를 가하여 용해한 다음 228nm에서 흡광도를 측정하여 <수학식 2> 계산식을 이용하여 계산하였다. 대조구는 각각의 샘플의 염농도에 맞는 용액을 제조하여 대조구로 사용하였다.Angiotensin-I Converting Enzyme (ACE) is a 400 mg sodium borate buffer (pH 8.3) in 1 g of acetone powder purified from rabbit lungs (previously obtained from rabbit lungs). After adding mL and stirring for 24hr at 5 ° C, the supernatant obtained by centrifugation was used as ACE coenzyme solution. 50 μL of each of the extract powders obtained in Examples 1 to 5 was added 50 μL of ACE coenzyme solution and 100 μL of 0.1 M Sodium borate buffer (pH 8.3), followed by preincubation at 37 ° C. for 5 minutes. 50 μL of 0.5 mM His-His-Leu was added thereto as a substrate, followed by reaction at 37 ° C. for 30 minutes, and then 250 μL of 1 N HCl was added to stop the reaction. 1.5 mL of ethyl acetate was added thereto, stirred for 15 seconds, and centrifuged at 200 × g for 5 minutes to obtain a supernatant. The supernatant was completely dried, dissolved in distilled water, and absorbed at 228 nm, and then calculated using Equation 2. The control was used as a control to prepare a solution for the salt concentration of each sample.

Figure 112006055948393-PAT00002
Figure 112006055948393-PAT00002

S : 시료의 흡광도 SC : 시료 대조구의 흡광도S: absorbance of the sample SC: absorbance of the sample control

C : 대조구의 흡광도 CC : 대조구 대조구의 흡광도C: Absorbance of the control control CC: Absorbance of the control control

상기의 실험한 산더덕 추출물의 항고혈압효과에 대한 결과를 도 2에 나타내었다. ACE 저해효과도 암세포 증식억제 효과와 유사한 경향을 보였으며 열수 추출물에서 가장 높은 효과를 나타내었다. 또한 EtOH 추출물 중 EtOH의 농도가 낮은 추출구에서 높은 저해효과를 보였다. 열수추출물의 1.0 mg/mL에서 21.6%의 저해효과를 나타내었으며 7.0 mg/mL에서 68.4%의 높은 효능을 나타내었다. EtOH추출구 중 50% EtOH에서 가장 높은 효능을 보였으며, 9.0 mg/mL에서 52.8%의 저해효과를 나타내었다. 또한 효소 추출물의 경우에도 낮지만 항고혈압효과를 나타내는 것을 볼 수 있었다. 더욱이 7.0~12.0 mg/mL 농도에서는 70 및 100% EtOH 추출물보다 높은 (40.8~52.8%) 효능을 보였다. The results of the antihypertensive effect of the above-mentioned Shandeokdeok extract is shown in FIG. The ACE inhibitory effect was similar to that of cancer cell proliferation inhibitory effect and showed the highest effect in hydrothermal extract. In addition, the EtOH extract showed a high inhibitory effect in the extract of low concentration of EtOH. The inhibitory effect was 21.6% at 1.0 mg / mL of hot water extract and 68.4% at 7.0 mg / mL. EtOH extract showed the highest efficacy at 50% EtOH and showed an inhibitory effect of 52.8% at 9.0 mg / mL. In addition, even in the case of the enzyme extract was shown to exhibit an antihypertensive effect. Furthermore, at concentrations of 7.0-12.0 mg / mL, they showed higher efficacy (40.8-52.8%) than 70 and 100% EtOH extracts.

실시예Example 6:  6: 산더덕Sanderuck 추출물을 유효성분으로 하는 항암 및 항고혈압에 효과적인 더덕 기능성  Deodeok Functionality Effective against Anticancer and Antihypertension with Extract as an Active Ingredient 건강음료의Health drink 제조 Produce

실시예 1에 따라 제조된 산더덕 열수 추출액 7mL을 정제수 95mL와 혼합하였다. 상기 더덕 혼합액의 총 중량에 대하여 식품 첨가제로서 구연산 0.1g, 비타민 C 0.05g, 덱스트린 0.2g, 구연산나트륨 0.05g, 포도당 4.0g, 정백당 4.0g, 액상과당 5.0g을 상기 더덕 혼합액에 첨가하고 잘 용해되도록 5℃의 저온에서 1 시간 동안 혼합하였다. 상기의 혼합 용액을 Toyo No 5C 여과지로 여과하여 이물질을 제거하였다. 여과 후 상온에서 더덕 추출액, 정제수 및 식품첨가제의 혼합물을 65℃가 되도록 예열한 다음 탈기하고, 95℃에서 살균한 후 병에 충진하였다. 상기의 더덕 추출액을 포함하는 혼합물이 충진된 병을 85℃의 저온에서 살균하고 냉각한 다음 포장하여 더덕음료를 제조하였다. 7 mL of the sandalwood hot water extract prepared according to Example 1 was mixed with 95 mL of purified water. 0.1 g of citric acid, vitamin C 0.05 g, dextrin 0.2 g, sodium citrate 0.05 g, glucose 4.0 g, white sugar 4.0 g, and 5.0 g liquid fructose were added to the deodeok mixture as a food additive with respect to the total weight of the deodeok mixture. Mix at low temperature of 5 ° C. for 1 hour. The mixed solution was filtered through a Toyo No 5C filter paper to remove foreign substances. After filtration, the mixture of Deodeok extract, purified water and food additive was preheated to 65 ° C. and then degassed at room temperature, sterilized at 95 ° C., and then filled in a bottle. The bottle filled with the mixture containing the deodeok extract was sterilized at 85 ° C. at low temperature, cooled, and then packaged to prepare a deodeok beverage.

본 발명에 따른 더덕 추출물은 항암 및 항고혈압 활성이 있는 것이 확인되었으며, 따라서 이를 음료로 제조하였을 때 음용이 용이하며, 장기 복용시 항암 및 항고혈압의 예방 및 치료에 효과적인 것을 알 수 있다. 특히 본 발명에 따라 음료를 제조하였을 때 모든 연령층을 만족시킬 수 있으므로, 별도의 약품이나 거부감 있는 음식등으로 항암 및 항고혈압의 예방을 하기보다는 음용이 용이하고 맛도 좋은 본 발명에 따른 음료를 물처럼 음용함으로써, 항암 및 항고혈압을 예방할 수 있을 것이다. 또한, 가족내에 고혈압이나 암 병력이 있는 경우, 본 발명에 따른 음료 를 장기 복용함으로써, 유용 성분이 축적되어, 주된 성인병인 암 및 고혈압을 예방할 수 있을 것이다. Deodeok extract according to the present invention has been confirmed to have anti-cancer and antihypertensive activity, and thus it is easy to drink when prepared as a drink, it can be seen that effective in the prevention and treatment of anticancer and antihypertensive when taken for a long time. Particularly, when the beverage is prepared according to the present invention, all age groups may be satisfied, so that the beverage according to the present invention is easy to drink and tastes better than the prevention of anti-cancer and antihypertension with a separate drug or a refusal food. By drinking it, you will be able to prevent cancer and antihypertension. In addition, if there is a history of hypertension or cancer in the family, by taking the beverage according to the present invention for a long time, useful components will accumulate, thereby preventing cancer and hypertension, which are the main adult diseases.

Claims (21)

더덕을 물, 알코올, 또는 효소로 추출하여 얻은 것을 특징으로 하는 항암 및 항고혈압의 예방 및 치료에 효과적인 더덕 추출물.Deodeok extract effective in the prevention and treatment of anti-cancer and antihypertensive, characterized in that the deodeok obtained by extracting with water, alcohol, or enzyme. 제1항에 있어서, 상기 물로 추출한 더덕 추출물이 더덕을 90~150℃에서 3~6 시간동안 더덕 중량의 2~4 배의 물을 가하여 추출하고 여과하여 얻어진 열수 추출물인 것을 특징으로 하는 항암 및 항고혈압의 예방 및 치료에 효과적인 더덕 추출물.The anti-cancer and anti-cancer extract according to claim 1, wherein the deodeok extract extracted with water is a dehydrated hydrothermal extract obtained by extracting and filtering Deodeok by adding 2-4 times the weight of Deodeok at 90-150 ° C. for 3-6 hours. Deodeok extract effective in the prevention and treatment of high blood pressure. 제1항에 있어서, 상기 알코올로 추출한 더덕 추출물이 더덕을 90~150℃에서 3~6 시간동안 더덕 중량의 2~4 배의 알코올을 가하여 추출하고 여과하여 얻어진 알코올 추출물인 것을 특징으로 하는 항암 및 항고혈압의 예방 및 치료에 효과적인 더덕 추출물.[Claim 2] The anti-cancer extract according to claim 1, wherein the deodeok extract extracted with alcohol is an alcohol extract obtained by extracting and filtering deodeok by adding 2-4 times the weight of deodeok at 90-150 ° C. for 3-6 hours. Deodeok extract effective for the prevention and treatment of antihypertensive. 제1항에 있어서, 여기서 상기 알코올이 에탄올인 것을 특징으로 하는 항암 및 항고혈압의 예방 및 치료에 효과적인 더덕 추출물.The method of claim 1, wherein the alcohol is ethanol extract effective in the prevention and treatment of anticancer and antihypertensive, characterized in that the ethanol. 제3항에 있어서, 상기 알코올이 30~60%의 알코올인 것을 특징으로 하는 항암 및 항고혈압의 예방 및 치료에 효과적인 더덕 추출물.The extract of claim 3, wherein the alcohol is 30 to 60% of the alcohol, which is effective for the prevention and treatment of anticancer and antihypertension. 제1항에 있어서, 상기 효소로 추출한 더덕 추출물이 더덕을 더덕의 중량에 2~4 배의 물을 가한 후 0.5~0.9%의 효소를 첨가하여 pH를 4~6으로 조절한 후 36~38℃의 인큐베이터에서 4~6시간 추출한 후 여과지로 여과하여 얻어진 효소 추출물인 것을 특징으로 하는 항암 및 항고혈압의 예방 및 치료에 효과적인 더덕 추출물.According to claim 1, Deodeok extract extracted with the enzyme is added to 2 ~ 4 times the water to the weight of the deodeok and 0.5 ~ 0.9% of the enzyme is added to adjust the pH to 4 ~ 6 and then 36 ~ 38 ℃ Deodorant extract effective for the prevention and treatment of anticancer and antihypertensive, characterized in that the enzyme extract obtained by filtration with a filter paper after 4-6 hours extraction in the incubator. 제6항에 있어서, 상기 효소가 셀룰라아제(cellulase)인 것을 특징으로 하는 항암 및 항고혈압의 예방 및 치료에 효과적인 더덕 추출물.The deodeok extract of claim 6, wherein the enzyme is cellulase, which is effective for the prevention and treatment of anticancer and antihypertension. 제1항에 있어서, 상기 더덕 추출물이 분쇄기를 이용하여 분쇄한 후 추출된 것을 특징으로 하는 항암 및 항고혈압의 예방 및 치료에 효과적인 더덕 추출물.According to claim 1, Deodeok extract is effective for the prevention and treatment of anti-cancer and antihypertensive, characterized in that after extracting the ground using a mill. 제1항에 있어서, 상기 더덕 추출물이 동결하여 동결 건조기로 분말화 한 후 70~90메쉬(mesh)로 여과한 분말인 것을 특징으로 하는 항암 및 항고혈압의 예방 및 치료에 효과적인 더덕 추출물.According to claim 1, Deodeok extract is effective in the prevention and treatment of anti-cancer and antihypertensive, characterized in that the powder is frozen and powdered with a freeze dryer and then filtered through a 70 ~ 90 mesh (mesh). 제1항에 있어서, 상기 더덕이 산더덕 또는 밭더덕인 것을 특징으로 하는 항암 및 항고혈압의 예방 및 치료에 효과적인 더덕 추출물.According to claim 1, Deodeok extract is effective in the prevention and treatment of anti-cancer and antihypertensive, characterized in that the deodeok or deodeok. 제1항 내지 제10항 중 어느 한 항에 의해 제조된 더덕 추출물을 유효성분으 로 하며, Deodeok extract prepared by any one of claims 1 to 10 as an active ingredient, 상기 더덕 추출물이 전체 음료 중량당 0.01~0.1 중량%을 함유하는 것을 특징으로 하는 항암 및 항고혈압에 효과적인 더덕 기능성 건강음료. Deodeok functional health drink effective in anti-cancer and antihypertensive, characterized in that the deodeok extract contains 0.01 ~ 0.1% by weight of the total beverage. 제11항에 있어서, 상기 더덕 추출물이 더덕을 90~150℃에서 3~6 시간동안 더덕 중량의 2~4 배의 물을 가하여 추출하고 여과하여 얻어진 열수 추출물인 것을 특징으로 하는 항암 및 항고혈압의 예방 및 치료에 효과적인 더덕 기능성 음료.12. The anticancer and antihypertensive agent according to claim 11, wherein the deodeok extract is a hydrothermal extract obtained by extracting and filtering deodeok by adding 2-4 times the weight of deodeok at 90-150 ° C. for 3-6 hours. Deodeok functional drink effective for prevention and treatment. 항암 및 항고혈압에 효과적인 더덕 기능성 건강음료. Deodeok functional health drink effective anti-cancer and antihypertensive. 제11항에 있어서, 상기 더덕 추출액이 60 브릭스(Brix) 농축액 인 것을 특징으로 하는 항암 및 항고혈압에 효과적인 더덕 기능성 건강음료. 12. The deodeok functional healthy drink effective in anticancer and antihypertension according to claim 11, wherein the deodeok extract is 60 Brix concentrate. 제11항에 있어서, 상기 더덕 기능성 건강음료가 기타 첨가제로서, 당류 1~5중량%, 구연산 0.1~0.5중량%, 비타민 C 0.01~0.005중량%, 덱스트린 0.1~0.5중량%를 더 포함하는 것을 특징으로 하는 항암 및 항고혈압에 효과적인 더덕 기능성 건강음료. The method according to claim 11, wherein the functional health drink, the deodeok further comprises 1 to 5% by weight of sugar, 0.1 to 0.5% by weight of citric acid, 0.01 to 0.005% by weight of vitamin C, 0.1 to 0.5% by weight of dextrin. Deok functional health drink effective in anti-cancer and antihypertensive. 더덕을 분쇄기로 분쇄하는 단계,Grinding the deodeok with a grinder, 상기 분쇄된 더덕을 물, 알코올 또는 효소로 추출하는 단계,Extracting the pulverized deodeok with water, alcohol or enzyme, 상기 더덕 추출물을 유효성분으로 하여 총 음료 중량에 대하여 0.01~0.1중 량%로 포함되도록 정제수를 혼합하는 단계를 포함하는 것을 특징으로 하는 항암 및 항고혈압에 효과적인 더덕 기능성 건강 음료의 제조방법.A method for producing a deodeok functional health drink effective in anti-cancer and antihypertension, comprising the step of mixing purified water so that the deodeok extract as an active ingredient to be contained in an amount of 0.01 to 0.1% by weight based on the total beverage weight. 제15항에 있어서, 상기 추출물을 여과하는 단계를 더 포함하는 것을 특징으로 하는 항암 및 항고혈압에 효과적인 더덕 기능성 건강 음료의 제조방법.16. The method of claim 15, wherein the extract further comprises the step of filtering the extract, which is effective for anticancer and antihypertension. 제15항에 있어서, 상기 분쇄된 더덕을 물로 추출하는 단계가 더덕 분쇄물을 90~150℃에서 3~6 시간동안 더덕 중량의 2~4 배의 물을 가하여 추출하고 여과하는 단계를 포함하는 것을 특징으로 하는 항암 및 항고혈압에 효과적인 더덕 기능성 건강 음료의 제조방법.16. The method of claim 15, wherein the step of extracting the pulverized deodeok with water comprises the step of extracting and filtering by adding 2 to 4 times the weight of the deodeok powder at 90 ~ 150 ℃ for 3-6 hours. A method for producing a deodeok functional health drink effective for anticancer and antihypertension. 제15항에 있어서, 상기 분쇄된 더덕을 알코올로 추출하는 단계가 더덕 분쇄물을 90~150℃에서 3~6 시간동안 더덕 중량의 2~4 배의 알코올을 가하여 추출하고 여과하는 단계를 포함하는 것을 특징으로 하는 항암 및 항고혈압에 효과적인 더덕 기능성 건강 음료의 제조방법.16. The method of claim 15, wherein the step of extracting the pulverized deodeok with alcohol comprises extracting and filtering the deodorant pulverized product by adding 2 to 4 times the alcohol weight of deodeok for 3-6 hours at 90 ~ 150 ℃ A method for producing a deodeok functional health drink effective for anticancer and antihypertensive, characterized in that. 제16항에 있어서, 상기 알코올이 30~60%의 에탄올인 것을 특징으로 하는 항암 및 항고혈압에 효과적인 더덕 기능성 건강 음료의 제조방법.17. The method of claim 16, wherein the alcohol is 30-60% ethanol. 제15항에 있어서, 상기 분쇄된 더덕을 효소로 추출하는 단계가 더덕 분쇄물 을 더덕의 중량에 2~4 배의 물을 가한 후 0.5~0.9%의 효소를 첨가하여 pH를 4~6으로 조절한 후 36~38℃의 인큐베이터에서 4~6시간 추출한 후 여과지로 여과하는 단계를 포함하는 것을 특징으로 하는 항암 및 항고혈압에 효과적인 더덕 기능성 건강 음료의 제조방법.16. The method of claim 15, wherein the step of extracting the pulverized deodeok with enzyme is added to the weight of the deodeok 2 ~ 4 times the weight of the deodeok 0.5 to 0.9% of the enzyme is added to adjust the pH to 4-6 After extracting 4 to 6 hours in an incubator at 36 ~ 38 ℃ after the step of filtration with a filter paper characterized in that the anti-cancer and anti-hypertension effective method for producing a functional functional health drink effective. 제20항에 있어서, 상기 효소가 셀룰라아제(cellulase)인 것을 특징으로 하는 항암 및 항고혈압에 효과적인 더덕 기능성 건강 음료의 제조방법.21. The method of claim 20, wherein the enzyme is a cellulase, which is effective for anticancer and antihypertensive health.
KR1020060073497A 2006-08-03 2006-08-03 Functional Dodok Codonopsis lanceolata beverage and Method of preparing the same KR100814382B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020060073497A KR100814382B1 (en) 2006-08-03 2006-08-03 Functional Dodok Codonopsis lanceolata beverage and Method of preparing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020060073497A KR100814382B1 (en) 2006-08-03 2006-08-03 Functional Dodok Codonopsis lanceolata beverage and Method of preparing the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020070112633A Division KR100858100B1 (en) 2007-11-06 2007-11-06 Functional Dodok (Codonopsis lanceolata) beverage and Method of preparing the same

Publications (2)

Publication Number Publication Date
KR20080012546A true KR20080012546A (en) 2008-02-12
KR100814382B1 KR100814382B1 (en) 2008-03-18

Family

ID=39340644

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020060073497A KR100814382B1 (en) 2006-08-03 2006-08-03 Functional Dodok Codonopsis lanceolata beverage and Method of preparing the same

Country Status (1)

Country Link
KR (1) KR100814382B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102552410A (en) * 2012-01-16 2012-07-11 李永君 Medicine for treating hypertension disease and preparation method thereof
KR20200114061A (en) * 2019-03-27 2020-10-07 고려대학교 산학협력단 Composition for reducing high sensitivity C-reactive protein level in subjects with prehypertension comprising Codonopsis lanceolata extract
CN114259061A (en) * 2021-12-16 2022-04-01 吉林国瑞医药有限公司 Lactation promoting product composition containing Codonopsis lanceolata oligopeptide and preparation method and application thereof

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101186599B1 (en) 2009-05-28 2012-09-28 김도윤 Method for Preparing Functional Beverage make use of Codonopsis lanceolata
KR101432584B1 (en) 2011-11-04 2014-08-22 강원대학교산학협력단 Method for steamed and fermented Codonopsis lanceolata for boosting biological activity
KR102130401B1 (en) * 2018-09-07 2020-07-07 주식회사 웰파이토 Functional powder and method for preparing powdered tea comprising Codonopsis lanceolata extract
KR102104225B1 (en) * 2019-08-01 2020-04-24 세원셀론텍(주) Manufacturing method of callus extracts of Codonopsis lanceolata having increased active ingredients by using hydrolytic enzymes and utra high pressure extraction
KR20210063739A (en) 2019-11-25 2021-06-02 학교법인 송원대학교 Pear and Deodeok Juice

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1245703C (en) 2001-12-11 2006-03-15 精工爱普生株式会社 Display device and electronic machine
KR20030085726A (en) * 2002-05-01 2003-11-07 고천우 Manufacture method and drink used main stuff for codonopis lanceolata
CN1281718C (en) 2003-10-16 2006-10-25 中国石油化工股份有限公司 Cracking process for hydrocarbon oil
KR20050121815A (en) * 2004-06-23 2005-12-28 조찬욱 Health supplement food composed herbs plaster for preventing and reducing hypertension
KR100631073B1 (en) 2006-04-03 2006-10-04 연세대학교 산학협력단 Composition for preventing and treating alcoholic liver disease and alcoholic hyperlipidemia comprising the extract of codonopsis lanceolata

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102552410A (en) * 2012-01-16 2012-07-11 李永君 Medicine for treating hypertension disease and preparation method thereof
KR20200114061A (en) * 2019-03-27 2020-10-07 고려대학교 산학협력단 Composition for reducing high sensitivity C-reactive protein level in subjects with prehypertension comprising Codonopsis lanceolata extract
CN114259061A (en) * 2021-12-16 2022-04-01 吉林国瑞医药有限公司 Lactation promoting product composition containing Codonopsis lanceolata oligopeptide and preparation method and application thereof
CN114259061B (en) * 2021-12-16 2023-11-07 吉林国瑞医药有限公司 Lactation promoting product composition containing codonopsis pilosula oligopeptide and preparation method and application thereof

Also Published As

Publication number Publication date
KR100814382B1 (en) 2008-03-18

Similar Documents

Publication Publication Date Title
KR100814382B1 (en) Functional Dodok Codonopsis lanceolata beverage and Method of preparing the same
KR101158856B1 (en) Compositions for the prevention and treatment of obesity, hyperlipidemia, atherosclerosis, fatty liver, diabetes mellitus or metabolic syndrome comprising extracts or fractions of Glycine max leaves as an active ingredient
KR101490786B1 (en) Composition comprising water extracts from fomitella fraxinea (fr.) imaz. for treating or preventing obesity
KR20080113175A (en) The method for making functional drinks using phellinus linteus and product thereof
CN106456693A (en) Agent for preventing or ameliorating diabetes
KR100858100B1 (en) Functional Dodok (Codonopsis lanceolata) beverage and Method of preparing the same
US20180296615A1 (en) Pharmaceutical composition or functional health food for preventing and treating metabolic diseases, containing water extract of pleurotus eryngii var. ferulae (pf.) as active ingredient
CN102186488B (en) Pharmaceutical composition and health food composition containing youngia denticulata extract, fraction thereof, or compound isolated therefrom as active ingredient for improving liver function
KR102286429B1 (en) A composition for improving, preventing and treating bone-related disease comprising polysaccharide fraction isolated from Nelumbo nucifera leaf
KR101671961B1 (en) Manufacturing method of akebia quinata extract and functional food using the same
CN104023734A (en) Composition for preventing or treating hyperlipedemia containing a water extract of Pleurotus eryngii var. ferulae as active ingredient
KR100768830B1 (en) Extract of echinosophora koreensis removing hangover and having anti-oxidant activity
KR101494664B1 (en) fermented corni fructus composition with antioxidant activity and method of making the same
KR100758266B1 (en) Extract of chrysanthemum zawadskii removing hangover and having anti-oxidant activity
KR20170122470A (en) Extract of graviola fermented by phellinus linteus and manufacturing method thereof
KR20160036825A (en) Health functional food for preventing or treatment tumor
KR101817053B1 (en) Composition for anti-oxidant or anti-cancer or anti-obesity or immune-enhancing containing Codonopsis lanceolata extract
CN105380267B (en) A kind of functional food and preparation method thereof
KR20200081550A (en) Composition containing an fermented extract of protaetia brevitarsis seulensis as an active ingredient and manufacturing the same
KR20130082249A (en) Composition for preventing or improving the metabolic syndrome containing parthenocissus tricuspidata extract
KR102151643B1 (en) Composition comprising extract of Lentinula edodes for prevention or treatment of bone diseases
US20240226223A1 (en) Composition for preventing, improving, or treating muscle loss comprising green tea peptide composition
KR102478971B1 (en) Composition for bowel movement promotion or diet
KR100758267B1 (en) Compositions effective for removing hangover, which contain natural plant extracts
KR102039623B1 (en) Milk thistle granule composition for protecting hepatocyte and manufacturing method thereof

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E90F Notification of reason for final refusal
A107 Divisional application of patent
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130304

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20140305

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20150304

Year of fee payment: 8

LAPS Lapse due to unpaid annual fee